Your browser doesn't support javascript.
loading
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
Radonic, Teodora; Geurts-Giele, W R R; Samsom, Kris G; Roemen, Guido M J M; von der Thüsen, Jan H; Thunnissen, Erik; Meijssen, Isabelle C; Sleddens, Hein F B M; Dinjens, Winand N M; Boelens, Mirjam C; Weijers, Karin; Speel, Ernst Jan M; Finn, Stephen P; O'Brien, Cathal; van Wezel, Tom; Cohen, Danielle; Monkhorst, Kim; Roepman, Paul; Dubbink, H J.
Afiliação
  • Radonic T; Department of Pathology, Cancer Center Amsterdam, Vrije University, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: T.radonic@amsterdamumc.nl.
  • Geurts-Giele WRR; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Samsom KG; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Roemen GMJM; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • von der Thüsen JH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Thunnissen E; Department of Pathology, Cancer Center Amsterdam, Vrije University, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Meijssen IC; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Sleddens HFBM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Dinjens WNM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Boelens MC; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Weijers K; Department of Pathology, Cancer Center Amsterdam, Vrije University, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Speel EJM; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands; School for Oncology and Developmental Biology (GROW), Maastricht, The Netherlands.
  • Finn SP; Department of Histopathology, St. James's Hospital and Trinity College Dublin, Dublin, Ireland; Cancer Molecular Diagnostics, St. James's Hospital and Trinity College Dublin, Dublin, Ireland; Thoracic Oncology Research Group, Trinity Translational Medical Institute, St. James's Hospital and Trinity
  • O'Brien C; Department of Histopathology, St. James's Hospital and Trinity College Dublin, Dublin, Ireland; Cancer Molecular Diagnostics, St. James's Hospital and Trinity College Dublin, Dublin, Ireland; Thoracic Oncology Research Group, Trinity Translational Medical Institute, St. James's Hospital and Trinity
  • van Wezel T; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Cohen D; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Monkhorst K; Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.
  • Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
J Thorac Oncol ; 16(5): 798-806, 2021 05.
Article em En | MEDLINE | ID: mdl-33588111

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2021 Tipo de documento: Article